|
6USM
Structure of nuclease domain of human parvovirus B19 non-structural protein 1 in complex with zinc
Deposited 2019-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
27–392(366 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;1.2 M LiSo4 and sodium acetate tri-hydrate buffer of pH4.6
|
Resolution 3.37 Å
|
|
6WH0
Crystal structure of HyBcl-2-4 with HyBax BH3
Deposited 2020-04-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
27–392(366 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2M Magnesium chloride hexahydrate, 0.1 Bis Tris pH 5.5, 25% PEG 3350
|
Resolution 1.99 Å
R-free 0.268
|
|
7JHG
Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody
Deposited 2020-07-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain M
26–392(367 aa)
|
Not recorded
|
TAK 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
ADP ADENOSINE-5'-DIPHOSPHATE × 1
AMP ADENOSINE MONOPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å
|
|
7JHH
Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody
Deposited 2020-07-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain M
26–392(367 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
ADP ADENOSINE-5'-DIPHOSPHATE × 1
AMP ADENOSINE MONOPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.92 Å
|
|
8DEI
Structure of the Cac1 KER domain
Deposited 2022-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
27–392(366 aa)
Fragment:KER domain, residues 136-225
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;0.1 M Phosphate/citrate pH 4.2 and 30 % PEG 300
|
Resolution 2.81 Å
R-free 0.282
|
|
8DEI
Structure of the Cac1 KER domain
Deposited 2022-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
27–392(366 aa)
Fragment:KER domain, residues 136-225
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;0.1 M Phosphate/citrate pH 4.2 and 30 % PEG 300
|
Resolution 2.81 Å
R-free 0.282
|
|
8DEI
Structure of the Cac1 KER domain
Deposited 2022-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
27–392(366 aa)
Fragment:KER domain, residues 136-225
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 2
PO4 PHOSPHATE ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;0.1 M Phosphate/citrate pH 4.2 and 30 % PEG 300
|
Resolution 2.81 Å
R-free 0.282
|
|
8DEI
Structure of the Cac1 KER domain
Deposited 2022-06-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
27–392(366 aa)
Fragment:KER domain, residues 136-225
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;288 K;0.1 M Phosphate/citrate pH 4.2 and 30 % PEG 300
|
Resolution 2.81 Å
R-free 0.282
|
|
8E0P
Crystal structure of mouse APCDD1 in fusion with engineered MBP
Deposited 2022-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
29–392(364 aa)
|
Mutation:D84A, K85A, E174A, N175A, A217H, K221H, K241A, A314V, I319V, E361A, K364A, D365A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
PLM PALMITIC ACID × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;0.2 M ammonium citrate, pH 7.0, 20% PEG3350, 4% NDSB-256, 5% glycerol
|
Resolution 2.33 Å
R-free 0.239
|
|
8E0P
Crystal structure of mouse APCDD1 in fusion with engineered MBP
Deposited 2022-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
29–392(364 aa)
|
Mutation:D84A, K85A, E174A, N175A, A217H, K221H, K241A, A314V, I319V, E361A, K364A, D365A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
GOL GLYCEROL × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;0.2 M ammonium citrate, pH 7.0, 20% PEG3350, 4% NDSB-256, 5% glycerol
|
Resolution 2.33 Å
R-free 0.239
|
|
8E0P
Crystal structure of mouse APCDD1 in fusion with engineered MBP
Deposited 2022-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
29–392(364 aa)
|
Mutation:D84A, K85A, E174A, N175A, A217H, K221H, K241A, A314V, I319V, E361A, K364A, D365A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
PLM PALMITIC ACID × 1
GOL GLYCEROL × 1
DMX 3-[BENZYL(DIMETHYL)AMMONIO]PROPANE-1-SULFONATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;0.2 M ammonium citrate, pH 7.0, 20% PEG3350, 4% NDSB-256, 5% glycerol
|
Resolution 2.33 Å
R-free 0.239
|
|
8E0P
Crystal structure of mouse APCDD1 in fusion with engineered MBP
Deposited 2022-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
29–392(364 aa)
|
Mutation:D84A, K85A, E174A, N175A, A217H, K221H, K241A, A314V, I319V, E361A, K364A, D365A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
GOL GLYCEROL × 1
CL CHLORIDE ION × 1
DMX 3-[BENZYL(DIMETHYL)AMMONIO]PROPANE-1-SULFONATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;293 K;0.2 M ammonium citrate, pH 7.0, 20% PEG3350, 4% NDSB-256, 5% glycerol
|
Resolution 2.33 Å
R-free 0.239
|
|
8IIY
Crystal structure of MBP fused GAS41 YEATS domain in complex with H3K14ac peptide
Deposited 2023-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
27–392(366 aa)
|
Mutation:D108A, K109A, E198A, N199A, K265A
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;100 mM Tris buffer (pH 8.5) containing 20% (w/v) PEG monomethyl ether 2000, 200 mM trimethylamine N-oxide
|
Resolution 2.15 Å
R-free 0.247
|
|
8IIZ
Crystal structure of MBP fused GAS41 YEATS domain in complex with H3K27ac peptide
Deposited 2023-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
27–392(366 aa)
|
Mutation:D108A, K109A, E198A, N199A, K265A
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;100 mM Tris buffer (pH 8.5) containing 20% (w/v) PEG monomethyl ether 2000, 200 mM trimethylamine N-oxide
|
Resolution 2.10 Å
R-free 0.301
|
|
8SQB
The cryo-EM structure of the EcBAM/EspP(beta7-12) complex
Deposited 2023-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain F
26–392(367 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|
|
9B83
Cryo-EM structure of human ADAR1 in complex with dsRNA derived from human GLI1 gene
Deposited 2024-03-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
27–392(366 aa)
Chain B
27–392(366 aa)
|
Not recorded
|
IHP INOSITOL HEXAKISPHOSPHATE × 2
ZN ZINC ION × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
9B84
Cryo-EM structure of human ADAR1 in complex with dsRNA derived from HT2C gene
Deposited 2024-03-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
27–392(366 aa)
Chain B
27–392(366 aa)
|
Not recorded
|
IHP INOSITOL HEXAKISPHOSPHATE × 2
ZN ZINC ION × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9B89
Cryo-EM structure of human ADAR1 in complex with dsRNA derived from HT2C gene in the pre-editing state
Deposited 2024-03-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
27–392(366 aa)
Chain B
27–392(366 aa)
|
Not recorded
|
IHP INOSITOL HEXAKISPHOSPHATE × 2
ZN ZINC ION × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.87 Å
|
|
9BDT
Apolipoprotein B 100 bound to LDL receptor and legobody
Deposited 2024-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain B
27–384(358 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
CA CALCIUM ION × 7
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.40 Å
|
|
9COO
Nanobody 4 bound to Apolipoprotein B 100
Deposited 2024-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
27–384(358 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
CA CALCIUM ION × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.73 Å
|
|
9IVP
24-mer DARPin-apoferritin scaffold in complex with the maltose binding protein
Deposited 2024-07-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 48
PDB declaration: 48-meric
|
Chain AA
27–392(366 aa)
Chain B
27–392(366 aa)
Chain CA
27–392(366 aa)
Chain D
27–392(366 aa)
Chain EA
27–392(366 aa)
Chain F
27–392(366 aa)
Chain GA
27–392(366 aa)
Chain H
27–392(366 aa)
Chain IA
27–392(366 aa)
Chain J
27–392(366 aa)
Chain KA
27–392(366 aa)
Chain L
27–392(366 aa)
Chain MA
27–392(366 aa)
Chain N
27–392(366 aa)
Chain OA
27–392(366 aa)
Chain P
27–392(366 aa)
Chain QA
27–392(366 aa)
Chain R
27–392(366 aa)
Chain SA
27–392(366 aa)
Chain T
27–392(366 aa)
Chain UA
27–392(366 aa)
Chain W
27–392(366 aa)
Chain WA
27–392(366 aa)
Chain Y
27–392(366 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|